Clinical Trials : Dravet Syndrome

Not yet recruiting

Study Name: The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy
Condition:

Lennox-Gastaut Syndrome
Dravet Syndrome

Date: 2016-06-20
Interventions:

Procedure: 15-Lead ECG Subject

Enrolling by invitation

Study Name: An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes
Condition:

Epilepsy
Dravet Syndrome
Lenn
Date: 2014-08-21
Interventions: Drug: GWP42003-P Other Names:
- Cannabidiol
- CBD

Recruiting

Study Name: Genetics of Severe Early Onset Epilepsies
Condition:

Epilepsy
Epileptic Encephalopathy
Ohtahara Syndrome

Date

Active, not recruiting

Study Name: Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder
Condition: Seizures
Date: 2014-12-12
Interventions: Drug: Cannabidiol Oral Solution An oral solution containing pharmaceutical grade cannabidiol (nonplant-b

Active, not recruiting

Study Name: Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy
Condition: Epilepsy
Date: 2014-05-14
Interventions: Drug: Cannabidiol

Completed

Study Name: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome
Condition: Dravet Syndrome
Date: 2025-11-05
Interventions: The study drug, fenfluramine HCl, is an oral solution to be administered in equal doses twice daily (BID).It will be based on the current dose a

COMPLETED

Study Name: A Study to Gather Information About Overall Occurrence and New Cases of Dravet and Lennox-Gastaut Syndromes in Children, Teenagers and Adults in Spain
Condition: Dravet Syndrome (DS)
Date: 2025-11-05
Interventions: As this is an observational study, no intervention will be administered.

Search for Clinical Trial Results

Dravet Syndrome - 27 Studies Found

Status	Study
Not yet recruiting	Study Name: The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy Condition: Lennox-Gastaut Syndrome Dravet Syndrome Date: 2016-06-20 Interventions: Procedure: 15-Lead ECG Subject
Enrolling by invitation	Study Name: An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes Condition: Epilepsy Dravet Syndrome Lenn Date: 2014-08-21 Interventions: Drug: GWP42003-P Other Names: Cannabidiol CBD
Recruiting	Study Name: Genetics of Severe Early Onset Epilepsies Condition: Epilepsy Epileptic Encephalopathy Ohtahara Syndrome < Date: 2013-05-09
Active, not recruiting	Study Name: Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder Condition: Seizures Date: 2014-12-12 Interventions: Drug: Cannabidiol Oral Solution An oral solution containing pharmaceutical grade cannabidiol (nonplant-b
Active, not recruiting	Study Name: Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy Condition: Epilepsy Date: 2014-05-14 Interventions: Drug: Cannabidiol
Completed	Study Name: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome Condition: Dravet Syndrome Date: 2025-11-05 Interventions: The study drug, fenfluramine HCl, is an oral solution to be administered in equal doses twice daily (BID).It will be based on the current dose a
COMPLETED	Study Name: A Study to Gather Information About Overall Occurrence and New Cases of Dravet and Lennox-Gastaut Syndromes in Children, Teenagers and Adults in Spain Condition: Dravet Syndrome (DS) Date: 2025-11-05 Interventions: As this is an observational study, no intervention will be administered.